EMA Decision Time For GSK’s RSV Older Adult Vaccine & Roche’s Glofitamab For LBCL

 
• By Neena Brizmohun

A number of companies could soon find out whether the European Medicines Agency will back pan-EU marketing approval for their respective products.

RSV vaccine
GSK's RSV vaccine for older adults is among the products that are up for a CHMP opinion this week • Source: Shutterstock

More from Europe

More from Geography